Literature DB >> 28886889

Anti-influenza activity of diazaadamantanes combined with monoterpene moieties.

Evgeniy Suslov1, Vladimir V Zarubaev2, Alexander V Slita3, Konstantin Ponomarev1, Dina Korchagina1, Daniel M Ayine-Tora4, Jóhannes Reynisson4, Konstantin Volcho5, Nariman Salakhutdinov5.   

Abstract

The antiviral activity of several diaza-adamantanes containing monoterpenoid moieties against a rimantadine-resistant strain of the influenza A/Puerto Rico/8/34 (H1N1) virus was studied. Hetero-adamantanes containing monoterpene moieties at the aminal position of the heterocycle were found to exhibit lower activity compared to compounds with a diaza-adamantane fragment and a monoterpene moiety linked via an amino group at the 6-position of the hetero-adamantane ring. The highest selectivity index (a ratio of the 50% cytotoxic concentration to the 50% inhibitory concentration) out of 30 was observed for compound 8d, which contains a citronellal monoterpenoid moiety. Diaza-adamantane 8d was superior to its adamantane-containing analog 5 both in its anti-influenza activity and selectivity. Furthermore, 8d has more balanced physicochemical properties than 5, making the former a more promising drug candidate. Modelling these compounds against an influenza virus M2 ion channel predicted plausible binding modes to both the wild-type and the mutant (S31N).
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antivirals; Citronellal; Diaza-adamantane; Influenza; Myrtenal; Terpene

Mesh:

Substances:

Year:  2017        PMID: 28886889     DOI: 10.1016/j.bmcl.2017.08.062

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Azaadamantanes, a New Promising Scaffold for Medical Chemistry.

Authors:  E V Suslov; K Yu Ponomarev; K P Volcho; N F Salakhutdinov
Journal:  Russ J Bioorg Chem       Date:  2021-12-16       Impact factor: 0.796

2.  Synthesis of 2-Azaadamantan-6-one: A Missing Isomer.

Authors:  Jianbo Wu; Derek A Leas; Yuxiang Dong; Xiaofang Wang; Edward L Ezell; Douglas E Stack; Jonathan L Vennerstrom
Journal:  ACS Omega       Date:  2018-09-18

3.  ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.

Authors:  Satya Narayan; Srinivasa Ramisetti; Aruna S Jaiswal; Brian K Law; Ashona Singh-Pillay; Parvesh Singh; Shantu Amin; Arun K Sharma
Journal:  Eur J Med Chem       Date:  2018-10-23       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.